HPSE was shown to play a role in therapy resistance in breast cancer when tamoxifen was suggested to induce HPSE expression in estrogen receptor (ER)-positive breast cancer cells, thus imparting a growth advantage [38]. The gene discussed is ESR1; the disease is breast cancer.